Загрузка страницы

The First COVID-19 Vaccine in the Clinic: A Lecture with Stephane Bancel, CEO of Moderna

A public lecture and fireside chat with Stéphane Bancel, CEO of Moderna, the company which produced a batch of COVID-19 vaccines ready for clinical trials - from sequence identification through vaccine design and manufacturing to the first patient tested - in just 63 days.

Видео The First COVID-19 Vaccine in the Clinic: A Lecture with Stephane Bancel, CEO of Moderna канала MIT Laboratory for Financial Engineering
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
3 апреля 2020 г. 1:46:35
01:31:13
Другие видео канала
The Black–Scholes/Merton Derivatives Symposium: Dinner RemarksThe Black–Scholes/Merton Derivatives Symposium: Dinner RemarksThe Black–Scholes/Merton Derivatives Symposium: Beyond Black and ScholesThe Black–Scholes/Merton Derivatives Symposium: Beyond Black and ScholesWelcome Remarks and BackgroundWelcome Remarks and BackgroundState of the Union in Appendiceal CancerState of the Union in Appendiceal CancerCelebrating the Remarkable Life of Jack TreynorCelebrating the Remarkable Life of Jack TreynorNovel Pathways, Current Roadblocks, and Lessons Learned from Other DiseasesNovel Pathways, Current Roadblocks, and Lessons Learned from Other DiseasesThe Black–Scholes/Merton Derivatives Symposium: Risk Preferences Implied by Synthetic OptionsThe Black–Scholes/Merton Derivatives Symposium: Risk Preferences Implied by Synthetic OptionsThe Black–Scholes/Merton Derivatives Symposium: How Technology Shapes Organizations Through OptionsThe Black–Scholes/Merton Derivatives Symposium: How Technology Shapes Organizations Through OptionsRegulatory Pathways, Government Policy, and Related Considerations for Rare Diseases and BeyondRegulatory Pathways, Government Policy, and Related Considerations for Rare Diseases and BeyondThe Black–Scholes/Merton Derivatives Symposium: Regulatory and Policy PanelThe Black–Scholes/Merton Derivatives Symposium: Regulatory and Policy PanelThe Black–Scholes/Merton Derivatives Symposium: 46 Years and Counting: Real OptionsThe Black–Scholes/Merton Derivatives Symposium: 46 Years and Counting: Real OptionsThe Black–Scholes/Merton Derivatives Symposium: Lunch Panel DiscussionThe Black–Scholes/Merton Derivatives Symposium: Lunch Panel DiscussionThe Black–Scholes Merton Derivatives Symposium: Hedging Exotic Options Using Reinforcement LearningThe Black–Scholes Merton Derivatives Symposium: Hedging Exotic Options Using Reinforcement LearningThe Black–Scholes/Merton Derivatives Symposium: Closing RemarksThe Black–Scholes/Merton Derivatives Symposium: Closing RemarksThe Black–Scholes/Merton Derivatives Symposium: Option-Implied Crash IndexThe Black–Scholes/Merton Derivatives Symposium: Option-Implied Crash IndexFireside Chat: Greg Simon and Christopher AustinFireside Chat: Greg Simon and Christopher AustinI-SPY Clinical Trials: An Interview with Dr. Laura EssermanI-SPY Clinical Trials: An Interview with Dr. Laura EssermanPotential New Business and Legal Structures & New Sources of Capital to Fund Biomedical InnovationPotential New Business and Legal Structures & New Sources of Capital to Fund Biomedical InnovationCan Financial Engineering and Data Science Cure Cancer? by Andrew W. LoCan Financial Engineering and Data Science Cure Cancer? by Andrew W. LoIn Pursuit of the Perfect Portfolio: Harry M. MarkowitzIn Pursuit of the Perfect Portfolio: Harry M. MarkowitzIn Pursuit of the Perfect Portfolio: Eugene F. FamaIn Pursuit of the Perfect Portfolio: Eugene F. Fama
Яндекс.Метрика